NCT07133360

Brief Summary

Combination of vitamins and melatonine compared with the conventional use of ibuprofen after surgical third molar extraction

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 20, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 21, 2025

Completed
Last Updated

August 21, 2025

Status Verified

August 1, 2025

Enrollment Period

2 months

First QC Date

June 20, 2025

Last Update Submit

August 13, 2025

Conditions

Keywords

Vitamin BVitamin DMelatonineIbuprofenThird Molar

Outcome Measures

Primary Outcomes (3)

  • Post operative pain

    VAS pain scale

    10 DAYS

  • Swelling

    Face measurement for swelling

    7 DAYS

  • Trismus

    Opening limitation

    7 DAYS

Secondary Outcomes (2)

  • Rescue analgesia

    7 DAYS

  • Inflammatory profile

    7 days

Study Arms (2)

Ibuprofen 400

ACTIVE COMPARATOR

Three ibuprofen 400 doses

Procedure: Third molar extraction

Coctail mixed Drugs

EXPERIMENTAL

Vitamin D, Vitamin B and Melatonine at night instead Ibuprofen

Procedure: Third molar extraction

Interventions

Surgical third molar extraction with conventional medication

Coctail mixed DrugsIbuprofen 400

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy volunteers, non ibuprofen allergic, presence of impacted lower third molar

You may not qualify if:

  • Diseases that avoid surgical intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Complutense University of Madrid

Madrid, Spain

Location

MeSH Terms

Conditions

FaciesPainTrismus

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and SymptomsSpasmNeuromuscular ManifestationsNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

June 20, 2025

First Posted

August 21, 2025

Study Start

February 1, 2025

Primary Completion

April 1, 2025

Study Completion

May 1, 2025

Last Updated

August 21, 2025

Record last verified: 2025-08

Locations